Frank Kerrigan
Impact in
- Oncology top 5%
- PARP inhibition in cancer therapy
- Organic Chemistry top 10%
- Synthesis and Biological Evaluation
- Synthesis and biological activity
- Click Chemistry and Applications
Papers in
- Oncology 5
- PARP inhibition in cancer therapy 4
- Co-authors
- Keith Menear (4 shared papers)Xiaoling Cockcroft (4 shared papers)Niall M.B. Martin (4 shared papers)Graeme C.M. Smith (4 shared papers)Sylvie Gomez (2 shared papers)Ian T.W. Matthews (2 shared papers)Charlotte Knights (1 shared paper)Aaron Cranston (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Journal of the Chemical Society Perkin Transactions 1 (2 papers)Tetrahedron Letters (2 papers)Expert Opinion on Therapeutic Patents (1 paper)
- Partner nations
- United Kingdom
In The Last Decade
Frank Kerrigan
11 papers receiving 752 citations
Peers
Comparison fields: 5 of 73
- Oncology 463
- Organic Chemistry 222
- Physiology 31
- Molecular Biology 400
- Immunology 70
Countries citing papers authored by Frank Kerrigan
This map shows the geographic impact of Frank Kerrigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Kerrigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Kerrigan more than expected).
Fields of papers citing papers by Frank Kerrigan
This network shows the impact of papers produced by Frank Kerrigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Kerrigan. The network helps show where Frank Kerrigan may publish in the future.
Co-authors
The 23 scholars most cited alongside Frank Kerrigan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 489 | |
| 2 | 2005 | 79 | |
| 3 | 2005 | 72 | |
| 4 | 1999 | 40 | |
| 5 | 1998 | 32 | |
| 6 | 1996 | 26 | |
| 7 | 1996 | 14 | |
| 8 | 1998 | 9 | |
| 9 | 1998 | 7 | |
| 10 | 2006 | 4 | |
| 11 | 1982 | 3 |
About Frank Kerrigan
Frank Kerrigan is a scholar working on Organic Chemistry, Oncology, Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience, having authored 11 papers that have together received 775 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (4 papers), Toxin Mechanisms and Immunotoxins (2 papers), Cancer therapeutics and mechanisms (2 papers), Receptor Mechanisms and Signaling (2 papers), Neurotransmitter Receptor Influence on Behavior (2 papers), DNA Repair Mechanisms (1 paper), Phenothiazines and Benzothiazines Synthesis and Activities (1 paper) and Organic and Inorganic Chemical Reactions (1 paper). The work is most often cited by research in Oncology (463 citations), Organic Chemistry (222 citations), Physiology (31 citations), Molecular Biology (400 citations) and Immunology (70 citations). Frank Kerrigan has collaborated with scholars based in United Kingdom. Frequent co-authors include Keith Menear, Xiaoling Cockcroft, Niall M.B. Martin, Graeme C.M. Smith, Sylvie Gomez, Ian T.W. Matthews, Charlotte Knights, Aaron Cranston, Mark J. O’Connor and Stephen Moore. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Journal of the Chemical Society Perkin Transactions 1, Tetrahedron Letters and Expert Opinion on Therapeutic Patents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.